Top

Archives of Gynecology and Obstetrics

Published in:

01-06-2011 | Materno-fetal Medicine

Chorionic villus sampling and the risk of preeclamspia: a systematic review and meta-analysis

Authors: Ahmet Basaran, Mustafa Basaran, Betül Topatan

Published in: Archives of Gynecology and Obstetrics | Issue 6/2011

Abstract

Objective

To perform systematic review and meta-analysis to evaluate the risk of preeclampsia after chorionic villus sampling (CVS).

Data sources

A systematic search of PubMED and Web of Science from inception through August 2010, and bibliographies of review articles and eligible studies were performed.

Methods of study selection

Six studies reported the risk of preeclampsia after CVS. All of the identified studies were retrospective and included in analysis.

Tabulation, integration, and results

Reporting quality of the identified studies according to quality assessment scale for methodology in retrospective clinical reporting was moderate. Pooling was performed in two strata for control: (1) patients without any invasive prenatal diagnostic procedure served as control group: no significant difference was found in the odds ratio (OR) of preeclampsia (OR 0.79, 95% CI 0.38–1.64), severe preeclampsia (OR 0.49, 95% CI 0.04–5.78), gestational hypertension (OR 0.76, 95% CI 0.46–1.26), all pregnancy-induced hypertensive disorders (OR 0.80, 95% CI 0.46–1.41) between CVS and control groups. (2) Patients with amniocentesis combined with patients without any invasive prenatal diagnostic procedure served as control group: no significant difference was found in the OR of preeclampsia (OR 0.76, 95% CI 0.37–1.53), severe preeclampsia (OR 0.83, 95% CI 0.14–4.85), all pregnancy-induced hypertensive disorders (OR 0.92, 95% CI 0.55–1.53) between CVS and combined control groups.

Conclusion

None of the included studies were randomized prospective trials designed to investigate the effect of CVS on preeclampsia. Accordingly, this review is limited by the heterogeneity, small number and retrospective nature of the available studies. CVS does not seem to increase the risk of preeclampsia or other pregnancy-induced hypertensive disorders. However, randomized prospective trials that are designed to investigate the risk of preeclampsia after CVS are needed to make a definite conclusion.

Duley L (1992) Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol 99(7):547–553PubMedCrossRef

Gupta S, Agarwal A, Sharma RK (2005) The role of placental oxidative stress and lipid peroxidation in preeclampsia. Obstet Gynecol Surv 60(12):807–816PubMedCrossRef

Carty DM, Delles C, Dominiczak AF (2010) Preeclampsia and future maternal health. J Hypertens 28(7):1349–1355PubMedCrossRef

Lyall F (2006) Mechanisms regulating cytotrophoblast invasion in normal pregnancy and pre-eclampsia. Aust N Z J Obstet Gynaecol 46(4):266–273PubMedCrossRef

Farina A, Hasegawa J, Raffaelli S, Ceccarini C, Rapacchia G, Pittalis MC et al (2010) The association between preeclampsia and placental disruption induced by chorionic villous sampling. Prenat Diagn 30(6):571–574PubMed

Katiyar R, Kriplani A, Agarwal N, Bhatla N, Kabra M (2007) Detection of fetomaternal hemorrhage following chorionic villus sampling by Kleihauer Betke test and rise in maternal serum alpha feto protein. Prenat Diagn 27(2):139–142PubMedCrossRef

Silver RK, Wilson RD, Philip J, Thom EA, Zachary JM, Mohide P et al (2005) Late first-trimester placental disruption and subsequent gestational hypertension/preeclampsia. Obstet Gynecol 105(3):587–592PubMedCrossRef

Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283(15):2008–2012PubMedCrossRef

Rangel SJ, Kelsey J, Colby CE, Anderson J, Moss RL (2003) Development of a quality assessment scale for retrospective clinical studies in pediatric surgery. J Pediatr Surg 38(3):390–396 discussion -6PubMedCrossRef

10.

(2008) Review Manager (RevMan) [Computer program]. Version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration

11.

Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174PubMedCrossRef

12.

Grobman WA, Auger M, Shulman LP, Elias S (2009) The association between chorionic villus sampling and preeclampsia. Prenat Diagn 29(8):800–803PubMedCrossRef

13.

Lindgren P, Cederholm M, Haglund B, Axelsson O (2010) Invasive procedures for fetal karyotyping: no cause of subsequent gestational hypertension or pre-eclampsia. BJOG 117(11):1422–1425

14.

Odibo AO, Singla A, Gray DL, Dicke JM, Oberle B, Crane J (2010) Is chorionic villus sampling associated with hypertensive disorders of pregnancy? Prenat Diagn 30(1):9–13PubMed

15.

Adusumalli J, Han CS, Beckham S, Bartholomew ML, Williams J 3rd (2007) Chorionic villus sampling and risk for hypertensive disorders of pregnancy. Am J Obstet Gynecol 196(6):591e1–591e7 discussion e7CrossRef

16.

Khalil A, Akolekar R, Pandya P, Syngelaki A, Nicolaides K (2010) Chorionic villus sampling at 11–13 weeks of gestation and hypertensive disorders in pregnancy. Obstet Gynecol 116(2 Pt 1):374–380PubMedCrossRef

17.

Roberts JM, Myatt L, Spong CY, Thom EA, Hauth JC, Leveno KJ et al (2010) Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med 362(14):1282–1291PubMedCrossRef

18.

Philip J, Silver RK, Wilson RD, Thom EA, Zachary JM, Mohide P et al (2004) Late first-trimester invasive prenatal diagnosis: results of an international randomized trial. Obstet Gynecol 103(6):1164–1173PubMedCrossRef

19.

Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2009) Power analysis for meta-analysis

Title: Chorionic villus sampling and the risk of preeclamspia: a systematic review and meta-analysis
Authors: Ahmet Basaran
Mustafa Basaran
Betül Topatan
Publication date: 01-06-2011
Publisher: Springer-Verlag
Published in: Archives of Gynecology and Obstetrics / Issue 6/2011
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-011-1840-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Chorionic villus sampling and the risk of preeclamspia: a systematic review and meta-analysis

Abstract

Objective

Data sources

Methods of study selection

Tabulation, integration, and results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Data sources

Methods of study selection

Tabulation, integration, and results

Conclusion

Please log in to get access to this content

Other articles of this Issue 6/2011

Risk of peripartum hysterectomy by mode of delivery and prior obstetric history: data from a population-based study

Electroacupuncture for cervical ripening prior to labor induction: a randomized clinical trial

Investigation of the factors affecting the perinatal outcome of monochorionic diamniotic twins

Dose–response effect of interleukin (IL)-1β, tumour necrosis factor (TNF)-α, and interferon-γ on the in vitro production of epithelial neutrophil activating peptide-78 (ENA-78), IL-8, and IL-6 by human endometrial stromal cells

Influence of the mode of delivery on maternal and neonatal outcomes: a comparison between elective cesarean section and planned vaginal delivery in a low-risk obstetric population

Obstetrical and fetal outcomes of a new management strategy in patients with intra-hepatic cholestasis of pregnancy